ArticleFrontiers in immunology2025

Chemoradiotherapy followed by continued immunotherapy for out-of-field progression during consolidation in limited-stage SCLC: a case report.

Ying Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.